ANRO
ANRO
NYSE · Pharmaceuticals

Alto Neuroscience Inc

$24.71
+0.64 (+2.66%)
As of May 9, 1:48 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target -10.3% upside
Low Target $14.63
Average Target $22.17
High Target $27.87
Current Price $24.71
Current
$24.71
Target
$22.17
$14.63 $22.17 avg $27.87
Scenario Analysis
Bear Case
$14.63
-40.8%
Low target
Base Case
$22.17
-10.3%
Avg target
Bull Case
$27.87
+12.8%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$28.44
-13.1% from high
52-Week Low
$2.12
+1,065.6% from low
Target vs 52W High
$22.17
-22.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%